HomeCompareHSY vs HRC

HSY vs HRC: Dividend Comparison 2026

HSY yields 2.60% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HSY wins by $540.9K in total portfolio value· pulled ahead in Year 10
10 years
HSY
HSY
● Live price
2.60%
Share price
$213.55
Annual div
$5.56
5Y div CAGR
73.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.80M
Annual income
$2,142,632.58
Full HSY calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — HSY vs HRC

📍 HSY pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHSYHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HSY + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HSY pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HSY
Annual income on $10K today (after 15% tax)
$221.39/yr
After 10yr DRIP, annual income (after tax)
$1,821,237.69/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HSY beats the other by $611,322.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HSY + HRC for your $10,000?

HSY: 50%HRC: 50%
100% HRC50/50100% HSY
Portfolio after 10yr
$2.53M
Annual income
$1,783,031.11/yr
Blended yield
70.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HRC right now

HSY
Analyst Ratings
6
Buy
26
Hold
3
Sell
Consensus: Hold
Price Target
$229.21
+7.3% upside vs current
Range: $181.00 — $267.00
Altman Z
4.1
Piotroski
5/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HSY buys
14
HRC buys
1
PoliticianChamberTickerTypeAmountDate
Scott Mr Franklin🏢 House$HSY▼ Sell$1,001 - $15,0002026-02-10
Scott Mr Franklin🏢 House$HSY▼ Sell$1,001 - $15,0002026-02-10
Scott Mr Franklin🏢 House$HSY▼ Sell$50,001 - $100,0002026-02-10
Sheldon Whitehouse🏛 Senate$HSY▲ Buy$1,001 - $15,0002025-11-21
Sheldon Whitehouse🏛 Senate$HSY▲ Buy$1,001 - $15,0002025-11-21
Rob Bresnahan🏢 House$HSY▲ Buy$1,001 - $15,0002025-05-15
Marjorie Taylor Greene🏢 House$HSY▲ Buy$1,001 - $15,0002025-05-14
Marjorie Taylor Greene🏢 House$HSY▲ Buy$1,001 - $15,0002025-05-05
Dan Newhouse🏢 House$HSY▼ Sell$1,001 - $15,0002025-04-11
Rob Bresnahan🏢 House$HSY▼ Sell$1,001 - $15,0002025-04-08
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHSYHRC
Forward yield2.60%11.38%
Annual dividend / share$5.56$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR73.5%40.3%
Portfolio after 10y$2.80M$2.26M
Annual income after 10y$2,142,632.58$1,423,429.65
Total dividends collected$2.72M$2.14M
Payment frequencyquarterlyquarterly
SectorConsumer StaplesStock
Analyst consensusHoldHold

Year-by-year: HSY vs HRC ($10,000, DRIP)

YearHSY PortfolioHSY Income/yrHRC PortfolioHRC Income/yrGap
1$11,152$451.89$12,296$1,595.93$1.1KHRC
2$12,750$817.14$15,730$2,573.05$3.0KHRC
3$15,157$1,514.82$21,147$4,316.00$6.0KHRC
4$19,138$2,920.05$30,235$7,608.15$11.1KHRC
5$26,456$5,978.47$46,615$14,263.36$20.2KHRC
6$41,709$13,400.95$78,712$28,834.27$37.0KHRC
7$78,886$34,257.43$148,063$63,841.01$69.2KHRC
8$189,469$105,060.87$315,890$157,462.80$126.4KHRC
9$611,893$409,161.27$778,498$440,495.17$166.6KHRC
10← crossover$2,797,358$2,142,632.58$2,256,422$1,423,429.65+$540.9KHSY

HSY vs HRC: Complete Analysis 2026

HSYConsumer Staples

The Hershey Company, together with its subsidiaries, engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally. The company operates through three segments: North America Confectionery, North America Salty Snacks, and International. It offers chocolate and non-chocolate confectionery products; gum and mint refreshment products, including mints, chewing gums, and bubble gums; pantry items, such as baking ingredients, toppings, beverages, and sundae syrups; and snack items comprising spreads, meat snacks, bars and snack bites, mixes, popcorn, and protein bars. The company provides its products primarily under the Hershey's, Reese's, Kisses, Jolly Rancher, Almond Joy, Brookside, barkTHINS, Cadbury, Good & Plenty, Heath, Kit Kat, Payday, Rolo, Twizzlers, Whoppers, York, Ice Breakers, Breath Savers, Bubble Yum, Lily's, SkinnyPop, Pirates Booty, Paqui, Dot's Homestyle Pretzels, and ONE Bar brands, as well as under the Pelon Pelo Rico, IO-IO, and Sofit brands. It markets and sells its products to wholesale distributors, chain grocery stores, mass merchandisers, chain drug stores, vending companies, wholesale clubs, convenience stores, dollar stores, concessionaires, and department stores. The company was founded in 1894 and is headquartered in Hershey, Pennsylvania.

Full HSY Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this HSY vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HSY vs SCHDHSY vs JEPIHSY vs OHSY vs KOHSY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.